In vivo characterization of the liver fat 1H MR spectrum

Gavin Hamilton, Takeshi Yokoo, Mark Bydder, Irene Cruite, Michael E. Schroeder, Claude B. Sirlin, Michael S. Middleton

Research output: Contribution to journalArticle

285 Citations (Scopus)

Abstract

A theoretical triglyceride model was developed for in vivo human liver fat 1H MRS characterization, using the number of double bonds (-CH=CH-), number of methylene-interrupted double bonds (-CH=CH-CH 2-CH=CH-) and average fatty acid chain length. Five 3 T, single-voxel, stimulated echo acquisition mode spectra (STEAM) were acquired consecutively at progressively longer TEs in a fat-water emulsion phantom and in 121 human subjects with known or suspected nonalcoholic fatty liver disease. T 2-corrected peak areas were calculated. Phantom data were used to validate the model. Human data were used in the model to determine the complete liver fat spectrum. In the fat-water emulsion phantom, the spectrum predicted by the model (based on known fatty acid chain distribution) agreed closely with spectroscopic measurement. In human subjects, areas of CH 2 peaks at 2.1 and 1.3ppm were linearly correlated (slope, 0.172; r=0.991), as were the 0.9ppm CH 3 and 1.3ppm CH 2 peaks (slope, 0.125; r=0.989). The 2.75ppm CH 2 peak represented 0.6% of the total fat signal in high-liver-fat subjects. These values predict that 8.6% of the total fat signal overlies the water peak. The triglyceride model can characterize human liver fat spectra. This allows more accurate determination of liver fat fraction from MRI and MRS.

Original languageEnglish (US)
Pages (from-to)784-790
Number of pages7
JournalNMR in Biomedicine
Volume24
Issue number7
DOIs
StatePublished - Aug 2011

Fingerprint

Liver
Fats
Emulsions
Water
Triglycerides
Fatty Acids
Chain length
Magnetic resonance imaging
Theoretical Models

Keywords

  • H MRS
  • Fat fraction
  • Liver
  • NAFLD
  • Quantification
  • Triglyceride

ASJC Scopus subject areas

  • Spectroscopy
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Hamilton, G., Yokoo, T., Bydder, M., Cruite, I., Schroeder, M. E., Sirlin, C. B., & Middleton, M. S. (2011). In vivo characterization of the liver fat 1H MR spectrum. NMR in Biomedicine, 24(7), 784-790. https://doi.org/10.1002/nbm.1622

In vivo characterization of the liver fat 1H MR spectrum. / Hamilton, Gavin; Yokoo, Takeshi; Bydder, Mark; Cruite, Irene; Schroeder, Michael E.; Sirlin, Claude B.; Middleton, Michael S.

In: NMR in Biomedicine, Vol. 24, No. 7, 08.2011, p. 784-790.

Research output: Contribution to journalArticle

Hamilton, G, Yokoo, T, Bydder, M, Cruite, I, Schroeder, ME, Sirlin, CB & Middleton, MS 2011, 'In vivo characterization of the liver fat 1H MR spectrum', NMR in Biomedicine, vol. 24, no. 7, pp. 784-790. https://doi.org/10.1002/nbm.1622
Hamilton G, Yokoo T, Bydder M, Cruite I, Schroeder ME, Sirlin CB et al. In vivo characterization of the liver fat 1H MR spectrum. NMR in Biomedicine. 2011 Aug;24(7):784-790. https://doi.org/10.1002/nbm.1622
Hamilton, Gavin ; Yokoo, Takeshi ; Bydder, Mark ; Cruite, Irene ; Schroeder, Michael E. ; Sirlin, Claude B. ; Middleton, Michael S. / In vivo characterization of the liver fat 1H MR spectrum. In: NMR in Biomedicine. 2011 ; Vol. 24, No. 7. pp. 784-790.
@article{01b502237195493ba13f96a8f1d35d3e,
title = "In vivo characterization of the liver fat 1H MR spectrum",
abstract = "A theoretical triglyceride model was developed for in vivo human liver fat 1H MRS characterization, using the number of double bonds (-CH=CH-), number of methylene-interrupted double bonds (-CH=CH-CH 2-CH=CH-) and average fatty acid chain length. Five 3 T, single-voxel, stimulated echo acquisition mode spectra (STEAM) were acquired consecutively at progressively longer TEs in a fat-water emulsion phantom and in 121 human subjects with known or suspected nonalcoholic fatty liver disease. T 2-corrected peak areas were calculated. Phantom data were used to validate the model. Human data were used in the model to determine the complete liver fat spectrum. In the fat-water emulsion phantom, the spectrum predicted by the model (based on known fatty acid chain distribution) agreed closely with spectroscopic measurement. In human subjects, areas of CH 2 peaks at 2.1 and 1.3ppm were linearly correlated (slope, 0.172; r=0.991), as were the 0.9ppm CH 3 and 1.3ppm CH 2 peaks (slope, 0.125; r=0.989). The 2.75ppm CH 2 peak represented 0.6{\%} of the total fat signal in high-liver-fat subjects. These values predict that 8.6{\%} of the total fat signal overlies the water peak. The triglyceride model can characterize human liver fat spectra. This allows more accurate determination of liver fat fraction from MRI and MRS.",
keywords = "H MRS, Fat fraction, Liver, NAFLD, Quantification, Triglyceride",
author = "Gavin Hamilton and Takeshi Yokoo and Mark Bydder and Irene Cruite and Schroeder, {Michael E.} and Sirlin, {Claude B.} and Middleton, {Michael S.}",
year = "2011",
month = "8",
doi = "10.1002/nbm.1622",
language = "English (US)",
volume = "24",
pages = "784--790",
journal = "NMR in Biomedicine",
issn = "0952-3480",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - In vivo characterization of the liver fat 1H MR spectrum

AU - Hamilton, Gavin

AU - Yokoo, Takeshi

AU - Bydder, Mark

AU - Cruite, Irene

AU - Schroeder, Michael E.

AU - Sirlin, Claude B.

AU - Middleton, Michael S.

PY - 2011/8

Y1 - 2011/8

N2 - A theoretical triglyceride model was developed for in vivo human liver fat 1H MRS characterization, using the number of double bonds (-CH=CH-), number of methylene-interrupted double bonds (-CH=CH-CH 2-CH=CH-) and average fatty acid chain length. Five 3 T, single-voxel, stimulated echo acquisition mode spectra (STEAM) were acquired consecutively at progressively longer TEs in a fat-water emulsion phantom and in 121 human subjects with known or suspected nonalcoholic fatty liver disease. T 2-corrected peak areas were calculated. Phantom data were used to validate the model. Human data were used in the model to determine the complete liver fat spectrum. In the fat-water emulsion phantom, the spectrum predicted by the model (based on known fatty acid chain distribution) agreed closely with spectroscopic measurement. In human subjects, areas of CH 2 peaks at 2.1 and 1.3ppm were linearly correlated (slope, 0.172; r=0.991), as were the 0.9ppm CH 3 and 1.3ppm CH 2 peaks (slope, 0.125; r=0.989). The 2.75ppm CH 2 peak represented 0.6% of the total fat signal in high-liver-fat subjects. These values predict that 8.6% of the total fat signal overlies the water peak. The triglyceride model can characterize human liver fat spectra. This allows more accurate determination of liver fat fraction from MRI and MRS.

AB - A theoretical triglyceride model was developed for in vivo human liver fat 1H MRS characterization, using the number of double bonds (-CH=CH-), number of methylene-interrupted double bonds (-CH=CH-CH 2-CH=CH-) and average fatty acid chain length. Five 3 T, single-voxel, stimulated echo acquisition mode spectra (STEAM) were acquired consecutively at progressively longer TEs in a fat-water emulsion phantom and in 121 human subjects with known or suspected nonalcoholic fatty liver disease. T 2-corrected peak areas were calculated. Phantom data were used to validate the model. Human data were used in the model to determine the complete liver fat spectrum. In the fat-water emulsion phantom, the spectrum predicted by the model (based on known fatty acid chain distribution) agreed closely with spectroscopic measurement. In human subjects, areas of CH 2 peaks at 2.1 and 1.3ppm were linearly correlated (slope, 0.172; r=0.991), as were the 0.9ppm CH 3 and 1.3ppm CH 2 peaks (slope, 0.125; r=0.989). The 2.75ppm CH 2 peak represented 0.6% of the total fat signal in high-liver-fat subjects. These values predict that 8.6% of the total fat signal overlies the water peak. The triglyceride model can characterize human liver fat spectra. This allows more accurate determination of liver fat fraction from MRI and MRS.

KW - H MRS

KW - Fat fraction

KW - Liver

KW - NAFLD

KW - Quantification

KW - Triglyceride

UR - http://www.scopus.com/inward/record.url?scp=80051586308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051586308&partnerID=8YFLogxK

U2 - 10.1002/nbm.1622

DO - 10.1002/nbm.1622

M3 - Article

C2 - 21834002

AN - SCOPUS:80051586308

VL - 24

SP - 784

EP - 790

JO - NMR in Biomedicine

JF - NMR in Biomedicine

SN - 0952-3480

IS - 7

ER -